HK1021885A1 - The use of hydrogen as active pharmaceutical compound in the preparation of pharmaceutica - Google Patents

The use of hydrogen as active pharmaceutical compound in the preparation of pharmaceutica

Info

Publication number
HK1021885A1
HK1021885A1 HK00100748A HK00100748A HK1021885A1 HK 1021885 A1 HK1021885 A1 HK 1021885A1 HK 00100748 A HK00100748 A HK 00100748A HK 00100748 A HK00100748 A HK 00100748A HK 1021885 A1 HK1021885 A1 HK 1021885A1
Authority
HK
Hong Kong
Prior art keywords
hydrogenous
hydrogen
gas mixtures
pharmaceutica
preparation
Prior art date
Application number
HK00100748A
Other languages
English (en)
Inventor
Manfred Eschwey
Christian Krebs
Rolf Van Bonn
Peter Germann
Original Assignee
Messer Group Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19634530A external-priority patent/DE19634530A1/de
Priority claimed from DE1997134279 external-priority patent/DE19734279A1/de
Application filed by Messer Group Gmbh filed Critical Messer Group Gmbh
Publication of HK1021885A1 publication Critical patent/HK1021885A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK00100748A 1996-08-27 2000-02-10 The use of hydrogen as active pharmaceutical compound in the preparation of pharmaceutica HK1021885A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19634530A DE19634530A1 (de) 1996-08-27 1996-08-27 Mittel und Verfahren zur Veränderung der Bildungsgeschwindigkeit und/oder Halbwertszeit reaktiver Molekülspezies
DE1997134279 DE19734279A1 (de) 1997-08-07 1997-08-07 Wasserstoffhaltiges Medikament
PCT/EP1997/004567 WO1998008523A1 (de) 1996-08-27 1997-08-22 Wasserstoffhaltiges medikament

Publications (1)

Publication Number Publication Date
HK1021885A1 true HK1021885A1 (en) 2000-07-14

Family

ID=26028775

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100748A HK1021885A1 (en) 1996-08-27 2000-02-10 The use of hydrogen as active pharmaceutical compound in the preparation of pharmaceutica

Country Status (11)

Country Link
EP (1) EP0921807B1 (da)
JP (1) JP2000517311A (da)
CN (1) CN1191836C (da)
AT (1) ATE253372T1 (da)
DE (1) DE59710969D1 (da)
DK (1) DK0921807T3 (da)
ES (1) ES2210585T3 (da)
HK (1) HK1021885A1 (da)
HR (1) HRP970465A2 (da)
PT (1) PT921807E (da)
WO (1) WO1998008523A1 (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
CA2451266A1 (en) 2001-06-21 2003-01-03 Beth Israel Deaconess Medical Center Inc. Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
EA200401070A1 (ru) 2002-02-13 2005-02-24 Бет Изрейэл Диконисс Медикал Сентер, Инк. Способы лечения сосудистых заболеваний
US8097585B2 (en) 2002-04-15 2012-01-17 Beth Israel Deaconess Medical Center, Inc. Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
MXPA04010242A (es) 2002-04-15 2005-06-08 Univ Pittsburgh Metodos para tratar enterocolitis necrotizante.
JP4588325B2 (ja) 2002-04-15 2010-12-01 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション イレウスの治療方法
US20050170011A1 (en) * 2002-04-26 2005-08-04 Tomoyuki Yanagihara Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof
RS96904A (en) * 2002-05-09 2007-02-05 Yale University, Carbon monoxide as a biomarker and therapeutic agent
PL205066B1 (pl) 2002-05-17 2010-03-31 Univ Pittsburgh Zastosowanie tlenku węgla do wytwarzania kompozycji farmaceutycznej
WO2006064539A1 (ja) * 2004-12-13 2006-06-22 Wataru Murota 還元性生理食塩水及びその製造方法
JP5106110B2 (ja) 2005-08-19 2012-12-26 成男 太田 生体内の有害な活性酸素及び／又はフリーラジカル除去剤
JPWO2008026785A1 (ja) 2006-08-31 2010-01-21 太田　成男 水素分子を含む脂質代謝改善剤
DE102008054205A1 (de) * 2008-10-31 2010-05-06 Bayer Schering Pharma Aktiengesellschaft Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie
EP2474327A1 (en) 2011-01-07 2012-07-11 RWTH Aachen Microdosing of ultrasound contrast agents
US8668937B2 (en) 2011-03-17 2014-03-11 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
EP2545908A1 (en) 2011-07-11 2013-01-16 RWTH Aachen Medium for microbubbles or microparticles and preparation thereof
CN103565822B (zh) * 2012-08-05 2015-03-25 熊江 氢气饱和生理盐水在制备防治腹主动脉瘤药物中的应用
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
CN103099780B (zh) * 2012-12-11 2015-11-25 中国科学院深圳先进技术研究院 制备含氢气微泡水溶液的方法，其产品及应用
WO2014140197A1 (en) 2013-03-15 2014-09-18 Westfaelische Wilhelms-Universitaet Muenster Detection of acute renal allograft rejection
US10160949B2 (en) 2013-10-31 2018-12-25 Tokyo Metropolitan Geriatric Hospital And Institute Of Gerontology Agent for improving sperm-motility
CN103690481B (zh) * 2013-12-23 2016-09-07 中国人民解放军第二军医大学 甲烷注射液在制备治疗缺血再灌注损伤药物中的应用
TWI590837B (zh) * 2014-03-25 2017-07-11 林信湧 一種用於治療心臟病之吸入式醫藥組成物及其備製方法
TWI594772B (zh) * 2014-04-18 2017-08-11 林信湧 一種用於治療高血壓之吸入式醫藥組成物及其備製方法
TWI601542B (zh) * 2014-04-18 2017-10-11 林信湧 一種用於治療肺癌之吸入式醫藥組成物及其備製方法
TWI590838B (zh) * 2014-04-18 2017-07-11 林信湧 一種用於治療糖尿病之吸入式醫藥組成物及其備製方法
TWI586382B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療腎臟病之吸入式醫藥組成物及其備製方法
JP2017143752A (ja) * 2016-02-15 2017-08-24 Ｈａｃｋ Ｊａｐａｎ ホールディングス株式会社 サプリメント
PL3484486T3 (pl) * 2016-07-15 2023-12-11 H2 Water Technologies Ltd Kompozycja do produkcji wody bogatej w wodór
CA3049278A1 (en) * 2017-01-05 2018-07-12 Warren Lee Apparatus, method, and use for ultrasound mediated microbubble delivery of pharmaceutical compositions
WO2018211474A1 (en) 2017-05-19 2018-11-22 Trudell Medical International Positive expiratory pressure device
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
CA3104889A1 (en) 2018-07-23 2020-01-30 Nutragenom, Llc Composition and methods for generating and sustaining molecular hydrogen (h2) in aqueous systems
JP6628449B1 (ja) * 2018-07-30 2020-01-08 国立大学法人名古屋大学 閉塞性気道疾患の抑制又は軽減のための組成物
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud
JP6667817B1 (ja) * 2019-03-13 2020-03-18 住友精化株式会社 ガス組成物及びその製造方法、並びにガス製品
US20220395528A1 (en) * 2019-11-08 2022-12-15 School Juridical Person The Kitasato Institute Agent for preventing or treating arrhythmia and device for preventing or treating arrhythmia
CN113318123A (zh) * 2020-02-28 2021-08-31 ＭｉＺ株式会社 用于预防和/或改善肺炎的含分子态氢组合物
CN114948990A (zh) * 2021-02-22 2022-08-30 上海市肺科医院 氢化镁在制备防治急性呼吸窘迫综合征疾病药物中的应用
CN114870839B (zh) * 2022-02-15 2023-11-10 中国科学院上海硅酸盐研究所 具有压电催化性能的无机纳米材料和催化制氢纳米反应器及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE407778B (sv) * 1977-09-06 1979-04-23 Astra Laekemedel Ab Forpackning och forfarande for skyddande av lekemedelsaktiva losningar innehallande oxidativt nedbrytbara substanser

Also Published As

Publication number Publication date
WO1998008523A1 (de) 1998-03-05
HRP970465A2 (en) 1998-08-31
EP0921807A1 (de) 1999-06-16
ES2210585T3 (es) 2004-07-01
CN1228706A (zh) 1999-09-15
DE59710969D1 (de) 2003-12-11
PT921807E (pt) 2004-04-30
DK0921807T3 (da) 2004-03-15
CN1191836C (zh) 2005-03-09
ATE253372T1 (de) 2003-11-15
EP0921807B1 (de) 2003-11-05
JP2000517311A (ja) 2000-12-26

Similar Documents

Publication Publication Date Title
HK1021885A1 (en) The use of hydrogen as active pharmaceutical compound in the preparation of pharmaceutica
EP0754069A4 (en) METHOD OF TREATING PULMONARY VASOCONSTRICTION AND ASTHMA
CA2198557A1 (en) Method and Apparatus for the Production of Nitric Oxide Gas Mixture
DE69526517D1 (de) Treibgasmischung für eine aerosolzubereitung
MD1900C2 (ro) Compoziţie farmaceutică de aerosol şi metodă de tratament al afecţiunilor respiratorii
BG103221A (en) Pharmaceutical composition in aerosol form
CA2097823A1 (en) Therapy for pulmonary vasoconstriction and asthma
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
GB0022222D0 (en) Pharmaceutical formulation of fluticasone propionate
UA27092C2 (uk) Спосіб формуваhhя дихальhої газової суміші і апарат для його реалізації
HUP0101608A2 (hu) Aeroszol formájú gyógyszerkészítmény és eljárás előállítására
DE59711548D1 (de) Treibmittelmischungen und aerosole für die mikronisierung von arzneimitteln mit hilfe dichter gase
BR9306060A (pt) Oxido nitrico de ar para usos medicos
GB2332372B (en) Pharmaceutical aerosol compositions
Jokanović et al. A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat
BR9712125A (pt) Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
SG49196A1 (en) Silver-containing alumina supported catalyst and the catalytic decomposition of dinitrogen monoxide which is pure or present in gas mixture
IL78017A (en) Sustained release tablets of theophylline
BR9912871A (pt) Catalisador cerâmico para a decomposição seletiva de n2o e método para a fabricação do mesmo
CA2314173A1 (fr) Utilisations therapeutiques de melanges gazeux d'helium et d'oxygene, en particulier dans le traitement de l'asthme
CZ220396A3 (en) Process of treating a medicament to aerosol, the use of a gas mixture and a therapeutical preparation
EP1110547A3 (en) Helium and neon as means delivering drug in inhaler
IT1261049B (it) Metodo per la preparazione e la lavorazione di propellenti.
US7629032B2 (en) Method for building up plasma on an optical fiber preform, while reducing nitrogen oxides
MY125374A (en) Metered dose inhalers with isobutane as propellant

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090822